| A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder (NCT00001381) | National Cancer Institute (NCI) | 1994-03-01 |
| A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate (NCT00001382) | National Cancer Institute (NCI) | 1994-03-01 |
| A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 (NCT00001383) | National Cancer Institute (NCI) | 1994-03-01 |
| Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin (NCT00002559) | Memorial Sloan Kettering Cancer Center | 1994-01-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors (NCT00002558) | Memorial Sloan Kettering Cancer Center | 1994-01-01 |
| A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer (NCT00001378) | National Cancer Institute (NCI) | 1994-01-01 |
| Gene Therapy for the Treatment of Fanconi's Anemia Type C (NCT00001399) | National Heart, Lung, and Blood Institute (NHLBI) | 1993-12-03 |
| To Demonstrate the Effect of Food on the Bioavailability of Glipizide (NCT00947024) | Sandoz | 1993-11-01 |
| Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop... (NCT00001396) | National Heart, Lung, and Blood Institute (NHLBI) | 1993-10-06 |
| Potential Risk Factors for Stroke (NCT00001368) | National Institute of Neurological Disorders and Stroke (NINDS) | 1993-10-01 |
| Stem Cell Factor Medication for Aplastic Anemia (NCT00001398) | National Heart, Lung, and Blood Institute (NHLBI) | 1993-10-01 |
| Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease (NCT00004667) | National Center for Research Resources (NCRR) | 1993-10-01 |
| PEG-Glucocerebrosidase for the Treatment of Gaucher Disease (NCT00001410) | National Institute of Mental Health (NIMH) | 1993-10-01 |
| A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease (NCT00001341) | National Cancer Institute (NCI) | 1993-09-01 |
| Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer (NCT00002537) | National Cancer Institute (NCI) | 1993-09-01 |
| To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets Under Non-Fasting Conditions (NCT00914160) | Sandoz | 1993-08-01 |
| To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets (NCT00946790) | Sandoz | 1993-07-01 |
| Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria (NCT00004789) | National Center for Research Resources (NCRR) | 1993-07-01 |
| Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor (NCT00144729) | Fred Hutchinson Cancer Center | 1993-05-01 |
| Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts (NCT00058812) | Baylor College of Medicine | 1993-05-01 |
| To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets (NCT00913224) | Sandoz | 1993-04-01 |
| Tobacco Cessation in Postmenopausal Women (Part II) - 2 (NCT00061074) | University of Minnesota | 1993-03-01 |
| Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer (NCT00014066) | Roswell Park Cancer Institute | 1993-03-01 |
| Alternate-Day Buprenorphine. Phase V - 6 (NCT00000224) | National Institute on Drug Abuse (NIDA) | 1993-02-01 |
| Phase I Study of Intrathecal Topotecan (NCT00001333) | National Cancer Institute (NCI) | 1993-02-01 |
| Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors (NCT00002754) | Duke University | 1993-02-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers (NCT00002752) | Duke University | 1993-02-01 |
| Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis (NCT00004779) | National Center for Research Resources (NCRR) | 1993-01-01 |
| Phase I Study of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Escalating Dose I.P. Platinum for Gastrointestinal Peritoneal Carcinomatosis (NCT00001332) | National Cancer Institute (NCI) | 1992-12-01 |
| Melphalan in Patients With Neoplastic Meningitis (NCT00002750) | Duke University | 1992-12-01 |
| To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted Conditions (NCT00913783) | Sandoz | 1992-11-01 |
| To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets (NCT00946504) | Sandoz | 1992-10-01 |
| A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 (NCT00001302) | National Cancer Institute (NCI) | 1992-09-01 |
| Gene Therapy for the Treatment of Brain Tumors (NCT00001328) | National Institute of Neurological Disorders and Stroke (NINDS) | 1992-08-21 |
| A Treatment Study for Premenstrual Syndrome (PMS) (NCT00001259) | National Institute of Mental Health (NIMH) | 1992-08-11 |
| Alternate-Day Buprenorphine Administration. Phase II - 4 (NCT00000222) | National Institute on Drug Abuse (NIDA) | 1992-07-01 |
| Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia (NCT00004809) | National Center for Research Resources (NCRR) | 1992-06-01 |
| Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults (NCT00698893) | GlaxoSmithKline | 1992-05-01 |
| Effects of Endotoxin in Normal Human Volunteers (NCT00001303) | National Institutes of Health Clinical Center (CC) | 1992-04-06 |
| Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma (NCT00002510) | Temple University | 1992-04-01 |
| Alternate-Day Buprenorphine Administration. Phase I - 3 (NCT00000221) | National Institute on Drug Abuse (NIDA) | 1992-04-01 |
| A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction (NCT00001298) | National Cancer Institute (NCI) | 1992-03-01 |
| Gene Therapy for ADA-SCID (NCT00599781) | IRCCS San Raffaele | 1992-03-01 |
| Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency (NCT00004801) | National Center for Research Resources (NCRR) | 1992-03-01 |
| Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients (NCT00699231) | GlaxoSmithKline | 1992-02-01 |
| Buprenorphine Dose Alteration Study - 1 (NCT00000219) | University of Vermont | 1991-12-01 |
| Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma (NCT00002748) | St. Jude Children's Research Hospital | 1991-12-01 |
| To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg (NCT00913341) | Sandoz | 1991-11-01 |
| High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer (NCT00002509) | Temple University | 1991-11-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas (NCT00002753) | Duke University | 1991-11-01 |
| Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer (NCT00002484) | Memorial Sloan Kettering Cancer Center | 1991-10-01 |
| A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients (NCT00001272) | National Cancer Institute (NCI) | 1991-09-01 |
| A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma (NCT00001271) | National Cancer Institute (NCI) | 1991-07-01 |
| Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer (NCT00002482) | St. Vincent Medical Center - Los Angeles | 1991-06-01 |
| Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma (NCT00001270) | National Cancer Institute (NCI) | 1991-06-01 |
| Gradual Vs. Rapid Buprenorphine Detoxification - 2 (NCT00000220) | National Institute on Drug Abuse (NIDA) | 1991-06-01 |
| Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer (NCT00001269) | National Cancer Institute (NCI) | 1991-05-01 |
| Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission (NCT00667927) | St. Jude Children's Research Hospital | 1991-03-01 |
| Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women (NCT01340521) | Milton S. Hershey Medical Center | 1991-03-01 |
| Radiation Therapy in Treating Patients With Prostate Cancer (NCT00002480) | Memorial Sloan Kettering Cancer Center | 1991-02-01 |
| Cocaine in Parotid Saliva, Blood and Urine - 4 (NCT00000190) | University of Pennsylvania | 1991-01-01 |
| Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors (NCT00002508) | Temple University | 1990-11-01 |
| Copper Histidine Therapy for Menkes Diseases (NCT00001262) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1990-06-01 |
| Intrathecal Mafosfamide (NCT00062881) | Baylor College of Medicine | 1990-06-01 |
| Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis (NCT00004368) | National Center for Research Resources (NCRR) | 1990-05-01 |
| Study of Radiolabeled Monoclonal Antibody Anti-B1 for the Treatment of B-Cell Lymphomas and Extended Study to Determine the Safety and Efficacy of Coulter Clone® 131Iodine-B1 Radioimmunotherapy of Advanced Non-Hodgkin's Lymphoma (NCT01536561) | GlaxoSmithKline | 1990-04-24 |
| To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets (NCT00913549) | Sandoz | 1989-12-01 |
| Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac (NCT00001249) | National Cancer Institute (NCI) | 1989-12-01 |
| Phase I Study of Intrathecal Mafosfamide (NCT00001251) | National Cancer Institute (NCI) | 1989-11-01 |
| To Demonstrate the Relative Bioavailability of Atenolol Tablets (NCT00913965) | Sandoz | 1989-07-01 |
| Monoclonal Antibody Therapy in Treating Patients With Brain Metastases (NCT00002751) | Duke University | 1989-07-01 |
| Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS) (NCT00392756) | Massachusetts General Hospital | 1989-04-01 |
| Leprosy Skin Test Antigens Phase 1 (NCT01920750) | National Institute of Allergy and Infectious Diseases (NIAID) | 1989-01-01 |
| To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets (NCT00913419) | Sandoz | 1988-11-01 |
| Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer (NCT00003582) | University of Miami | 1988-05-01 |
| A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS). (NCT00000393) | National Institute of Mental Health (NIMH) | 1988-01-01 |
| A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients. (NCT00000391) | National Institute of Mental Health (NIMH) | 1988-01-01 |
| Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells (NCT00001234) | National Institute of Neurological Disorders and Stroke (NINDS) | 1988-01-01 |
| To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin Tablets (NCT00913809) | Sandoz | 1987-12-01 |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma (NCT00002465) | St. Vincent Medical Center - Los Angeles | 1987-12-01 |
| To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets (NCT00913822) | Sandoz | 1987-12-01 |
| To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets (NCT00913237) | Sandoz | 1987-07-01 |
| To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers (NCT00946491) | Sandoz | 1987-04-01 |
| A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors (NCT00001209) | National Cancer Institute (NCI) | 1986-10-01 |
| Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis (NCT00004811) | National Center for Research Resources (NCRR) | 1985-03-01 |
| Inducing Systemic Immunity and Regressions in Metastatic Melanoma (NCT02350972) | NYU Langone Health | 1978-07-01 |
| Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59) (NCT00591643) | Memorial Sloan Kettering Cancer Center | 1977-07-01 |
| Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects (NCT01870102) | Daewon Pharmaceutical Co., Ltd. | |
| Study Evaluating MST-997 in Advanced Malignant Solid Tumors (NCT00088647) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia (NCT00002008) | Sandoz | |
| Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda (NCT00007423) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals (NCT00000772) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection (NCT00000812) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer (NCT00034463) | Eli Lilly and Company | |
| Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years (NCT01596413) | Kyowa Kirin Pharmaceutical Development Ltd | |
| A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease (NCT00000729) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries (NCT01101347) | Surpass Medical Ltd. | |
| Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox (NCT00001125) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients (NCT00000733) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of DPC 817 in HIV-Infected Males (NCT00040274) | Pharmasset | |